# OnCo record nct05411718 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct05411718/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct05411718", "NCT05411718" ;
  schema:name "A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome"@en ;
  schema:description "A phase 2 trial of aspirin in colorectal cancer, run by M.D. Anderson Cancer Center, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct05411718/> ;
  schema:dateModified "2026-09-24"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05411718> ;
  onco:status "recruiting" ;
  onco:tag "ctgov-ingest", "colorectal-deep-dive" ;
  onco:phase "2" ;
  onco:cancers <https://onco.cc/cancers/rectal-cancer/>, <https://onco.cc/cancers/colon-cancer/>, <https://onco.cc/cancers/msi-high-colorectal/> ;
  onco:drugs <https://onco.cc/drugs/aspirin/> .
